Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of LC51-0255 film-coated vs uncoated tablets in healthy subjects
NCT04360343Phase 1Completed
- Sponsor
- LG Chem
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of zectivimod in ulcerative colitis (UC) (2 arms), sponsored by LG Chem. Primary endpoints: Pharmacokinetic Outcome Measures and Pharmacodynamic Outcome Measures. Started Jul 2020; status: completed.
02
Drugs
zectivimod
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04360343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04360343.